METHYL SALICYLATE

METHYL SALICYLATE was reported 709 times

METHYL SALICYLATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 EXTRANODAL MARGINAL ZONE B-CELL LYMPHOMA (MALT TYPE) STAGE I 1 0.1429
1 ANTICIPATORY ANXIETY 11 0.0404
2 CYCLIC NEUTROPENIA 1 0.0192
3 PERITONEAL INFECTION 1 0.0122
4 MEDICAL DEVICE ENTRAPMENT 1 0.0119
5 FOOD INTOLERANCE 39 0.0106
6 BACILLUS TEST POSITIVE 1 0.0101
7 ANAL POLYP 1 0.0097
8 ANAL EROSION 1 0.0091
9 RHEUMATIC HEART DISEASE 1 0.0088
10 ABDOMINAL WALL CYST 1 0.0082
11 MEDIASTINAL ABSCESS 1 0.0077
12 INJECTION SITE INFLAMMATION 38 0.0076
13 LEUKAEMIC INFILTRATION 1 0.0071
14 WOUND HAEMATOMA 1 0.0069
15 SERRATIA BACTERAEMIA 1 0.0068
16 DIAGNOSTIC PROCEDURE 1 0.0066
17 ULTRASOUND DOPPLER ABNORMAL 1 0.0058
18 DIABETIC KETOACIDOTIC HYPERGLYCAEMIC COMA 1 0.0055
19 FAMILIAL MEDITERRANEAN FEVER 1 0.0051
20 DOPAMINE DYSREGULATION SYNDROME 2 0.0045
21 SHUNT INFECTION 1 0.0044
22 UROSEPSIS 40 0.0043
23 VITAMIN B6 DEFICIENCY 1 0.0041
24 INTESTINAL SEPSIS 1 0.0038
25 GRANULOMA SKIN 3 0.0037
26 PRODUCT INFORMATION CONTENT COMPLAINT 1 0.0036
27 CARBUNCLE 1 0.0035
28 SCARLET FEVER 1 0.0031
29 NOROVIRUS TEST POSITIVE 1 0.0031
30 FUNGAL TEST POSITIVE 1 0.0028
31 ACETABULUM FRACTURE 1 0.0027
32 LYMPHOCYTE PERCENTAGE INCREASED 1 0.0025
33 INFLUENZA A VIRUS TEST POSITIVE 1 0.0023
34 NEUROMA 1 0.0022
35 BLOOD PARATHYROID HORMONE DECREASED 3 0.0020
36 INFUSION SITE VESICLES 1 0.0019
37 WHITE COAT HYPERTENSION 1 0.0018
38 ENCEPHALOMALACIA 1 0.0018
39 BACTERIURIA 1 0.0018
40 STOMA SITE HYPERGRANULATION 1 0.0016
41 VAGINITIS BACTERIAL 1 0.0016
42 NEUTROPENIC SEPSIS 11 0.0015
43 INFUSION SITE URTICARIA 1 0.0015
44 PULMONARY FIBROSIS 28 0.0015
45 SUTURE RUPTURE 1 0.0014
46 SYNOVITIS 26 0.0014
47 DERMATITIS DIAPER 1 0.0014
48 HODGKIN'S DISEASE 1 0.0014
49 DRUG USE DISORDER 11 0.0013
50 MYOPERICARDITIS 1 0.0013
51 PANNICULITIS 3 0.0012
52 INCISION SITE COMPLICATION 1 0.0012
53 X-RAY ABNORMAL 2 0.0011
54 JOINT ARTHROPLASTY 2 0.0011
55 MUSCLE NECROSIS 1 0.0011
56 OVARIAN CYST 11 0.0011
57 RHEUMATOID NODULE 3 0.0011
58 DRUG TOLERANCE DECREASED 3 0.0011
59 RED BLOOD CELL SEDIMENTATION RATE INCREASED 11 0.0010
60 SUSPECTED PRODUCT CONTAMINATION 1 0.0010
61 IMPULSE-CONTROL DISORDER 2 0.0010
62 TEETH BRITTLE 1 0.0010
63 BURNS THIRD DEGREE 1 0.0009
64 LOCAL ANAESTHETIC SYSTEMIC TOXICITY 1 0.0009
65 ARRHYTHMIA SUPRAVENTRICULAR 1 0.0009
66 PNEUMONIA STREPTOCOCCAL 1 0.0009
67 RETROPERITONEAL HAEMATOMA 2 0.0009
68 ANGIOEDEMA 39 0.0009
69 PROGRESSIVE MULTIPLE SCLEROSIS 1 0.0009
70 LIP ULCERATION 1 0.0009
71 MAGNETIC RESONANCE IMAGING ABNORMAL 1 0.0008
72 ESCHERICHIA TEST POSITIVE 1 0.0008
73 BREATH SOUNDS ABNORMAL 4 0.0008
74 GASTROINTESTINAL SOUNDS ABNORMAL 4 0.0008
75 SKIN NECROSIS 4 0.0008
76 STOMA SITE INFECTION 1 0.0008
77 NON-HODGKIN'S LYMPHOMA 1 0.0008
78 LYMPHOCYTE PERCENTAGE DECREASED 1 0.0007
79 HYPOAESTHESIA ORAL 11 0.0007
80 CORNEAL ABRASION 1 0.0007
81 INFUSION SITE RASH 1 0.0007
82 OBSTRUCTIVE SLEEP APNOEA SYNDROME 1 0.0007
83 PULMONARY PAIN 2 0.0007
84 STOMA SITE PAIN 1 0.0007
85 CONTRAINDICATED PRODUCT ADMINISTERED 20 0.0007
86 NEOPLASM SKIN 1 0.0006
87 FUNGAEMIA 1 0.0006
88 ORTHOPNOEA 2 0.0006
89 ENTERITIS 4 0.0006
90 MEAN CELL HAEMOGLOBIN INCREASED 1 0.0006
91 DEAFNESS BILATERAL 1 0.0006
92 HEPATIC ENZYME INCREASED 40 0.0006
93 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 28 0.0006
94 SEPTIC SHOCK 25 0.0006
95 INFUSION SITE DISCHARGE 1 0.0006
96 ESSENTIAL HYPERTENSION 1 0.0005
97 LOBAR PNEUMONIA 1 0.0005
98 HEPATOTOXICITY 12 0.0005
99 STOMA SITE ERYTHEMA 1 0.0005
100 HYPERTENSIVE HEART DISEASE 1 0.0005
101 RHEUMATOID FACTOR POSITIVE 3 0.0005
102 JOINT INJURY 11 0.0005
103 ADRENOCORTICAL INSUFFICIENCY ACUTE 1 0.0005
104 MUSCLE HAEMORRHAGE 2 0.0005
105 GLOSSODYNIA 11 0.0005
106 DIVERTICULAR PERFORATION 1 0.0005
107 ARTHROPATHY 27 0.0005
108 DILATATION VENTRICULAR 1 0.0005
109 C-REACTIVE PROTEIN ABNORMAL 3 0.0005
110 JAW FRACTURE 1 0.0005
111 RENAL TUBULAR ACIDOSIS 1 0.0005
112 CORNEAL DISORDER 1 0.0005
113 GASTRITIS 12 0.0005
114 BACTERIAL TEST POSITIVE 1 0.0004
115 COMPUTERISED TOMOGRAM ABNORMAL 1 0.0004
116 BLOOD LOSS ANAEMIA 1 0.0004
117 METASTASES TO MENINGES 1 0.0004
118 RED BLOOD CELL SEDIMENTATION RATE ABNORMAL 1 0.0004
119 NECK SURGERY 1 0.0004
120 DYSPEPSIA 42 0.0004
121 INFLAMMATION 22 0.0004
122 RETROPERITONEAL HAEMORRHAGE 1 0.0004
123 HYPERVOLAEMIA 2 0.0004
124 DRUG INTOLERANCE 39 0.0004
125 CATHETER SITE HAEMORRHAGE 1 0.0004
126 ENDODONTIC PROCEDURE 1 0.0004
127 VENTRICULAR DYSFUNCTION 1 0.0004
128 ACTINIC KERATOSIS 1 0.0004
129 MOOD SWINGS 12 0.0004
130 GASTROINTESTINAL MOTILITY DISORDER 2 0.0004
131 BLOOD SODIUM INCREASED 1 0.0004
132 ANTIPSYCHOTIC DRUG LEVEL INCREASED 1 0.0004
133 RHEUMATOID ARTHRITIS 40 0.0004
134 HEART VALVE INCOMPETENCE 1 0.0003
135 PARAPLEGIA 1 0.0003
136 RALES 2 0.0003
137 INJECTION SITE PRURITUS 23 0.0003
138 GASTROINTESTINAL NECROSIS 1 0.0003
139 NIGHT SWEATS 11 0.0003
140 CREPITATIONS 1 0.0003
141 METABOLIC ENCEPHALOPATHY 1 0.0003
142 HYPERCAPNIA 1 0.0003
143 DYSCHEZIA 1 0.0003
144 INTRACARDIAC THROMBUS 1 0.0003
145 BLOOD CREATININE DECREASED 1 0.0003
146 INFUSION SITE PRURITUS 1 0.0003
147 IRIDOCYCLITIS 1 0.0003
148 POLYMYALGIA RHEUMATICA 1 0.0003
149 EXPOSURE TO TOXIC AGENT 1 0.0003
150 LIVER ABSCESS 1 0.0003
151 MUSCULOSKELETAL STIFFNESS 27 0.0003
152 POSTURE ABNORMAL 1 0.0003
153 TREATMENT FAILURE 25 0.0003
154 PEPTIC ULCER 1 0.0003
155 HIGH DENSITY LIPOPROTEIN DECREASED 1 0.0003
156 LARGE INTESTINE PERFORATION 2 0.0003
157 ECZEMA 15 0.0003
158 APPARENT DEATH 1 0.0003
159 DRY EYE 13 0.0003
160 HYPOALBUMINAEMIA 2 0.0003
161 WOUND SECRETION 1 0.0003
162 SKIN PAPILLOMA 1 0.0002
163 BLEPHARITIS 1 0.0002
164 LIVER DISORDER 11 0.0002
165 INTERNATIONAL NORMALISED RATIO DECREASED 1 0.0002
166 ASPARTATE AMINOTRANSFERASE INCREASED 13 0.0002
167 SMALL INTESTINAL OBSTRUCTION 3 0.0002
168 HYPERCALCAEMIA 3 0.0002
169 AORTIC DISSECTION 1 0.0002
170 RED CELL DISTRIBUTION WIDTH INCREASED 1 0.0002
171 COAGULOPATHY 4 0.0002
172 CHAPPED LIPS 1 0.0002
173 ILEUS PARALYTIC 1 0.0002
174 ABDOMINAL HERNIA 1 0.0002
175 LUMBAR VERTEBRAL FRACTURE 1 0.0002
176 ISCHAEMIA 1 0.0002
177 HYPERTENSION 46 0.0002
178 BLOOD CHOLESTEROL ABNORMAL 1 0.0002
179 EPISTAXIS 16 0.0002
180 ALANINE AMINOTRANSFERASE INCREASED 13 0.0002
181 SUBCUTANEOUS ABSCESS 1 0.0002
182 LETHARGY 12 0.0002
183 HUMERUS FRACTURE 1 0.0002
184 HYPERCHOLESTEROLAEMIA 2 0.0002
185 ABDOMINAL TENDERNESS 1 0.0002
186 HYPERNATRAEMIA 1 0.0002
187 CORONARY ARTERY STENOSIS 1 0.0002
188 KLEBSIELLA INFECTION 1 0.0002
189 DYSPHORIA 1 0.0002
190 PATHOLOGICAL FRACTURE 1 0.0002
191 ASTHMA 22 0.0002
192 BENIGN PROSTATIC HYPERPLASIA 1 0.0002
193 SKIN ULCER 5 0.0002
194 BASAL CELL CARCINOMA 3 0.0002
195 POLYARTHRITIS 1 0.0002
196 ULCER 3 0.0002
197 ANAL ABSCESS 1 0.0002
198 SLEEP DISORDER 13 0.0002
199 HYDROCEPHALUS 1 0.0002
200 JAW DISORDER 1 0.0002
201 DEAFNESS UNILATERAL 1 0.0002
202 ARTHRITIS 14 0.0002
203 URINARY TRACT INFECTION 30 0.0002
204 CARDIAC VALVE DISEASE 1 0.0002
205 GASTROOESOPHAGEAL REFLUX DISEASE 14 0.0002
206 EXERCISE TOLERANCE DECREASED 1 0.0002
207 SOCIAL AVOIDANT BEHAVIOUR 1 0.0002
208 DRUG ERUPTION 3 0.0002
209 CARDIAC PACEMAKER INSERTION 1 0.0002
210 GOUT 3 0.0002
211 CHOLANGITIS 1 0.0002
212 SWELLING OF EYELID 1 0.0002
213 INFUSION SITE SWELLING 1 0.0002
214 GASTRIC ULCER 3 0.0002
215 ERECTILE DYSFUNCTION 4 0.0002
216 WALKING AID USER 1 0.0002
217 PRURITUS 58 0.0002
218 TERMINAL STATE 1 0.0001
219 LEFT VENTRICULAR DYSFUNCTION 1 0.0001
220 BRONCHIECTASIS 1 0.0001
221 DYSGEUSIA 11 0.0001
222 UVEITIS 2 0.0001
223 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 1 0.0001
224 PNEUMONIA 47 0.0001
225 HALLUCINATION, VISUAL 3 0.0001
226 PULMONARY TOXICITY 1 0.0001
227 LIQUID PRODUCT PHYSICAL ISSUE 1 0.0001
228 GASTROENTERITIS 2 0.0001
229 LOWER GASTROINTESTINAL HAEMORRHAGE 1 0.0001
230 ARTHROPOD BITE 1 0.0001
231 RENAL FAILURE CHRONIC 1 0.0001
232 HAEMOLYSIS 1 0.0001
233 LOW DENSITY LIPOPROTEIN INCREASED 1 0.0001
234 FEMUR FRACTURE 4 0.0001
235 ELECTROCARDIOGRAM ABNORMAL 1 0.0001
236 PRODUCT ADMINISTRATION INTERRUPTED 1 0.0001
237 ARTERIAL OCCLUSIVE DISEASE 1 0.0001
238 FURUNCLE 1 0.0001
239 DISORIENTATION 5 0.0001
240 RENAL CYST 1 0.0001
241 TRICUSPID VALVE INCOMPETENCE 1 0.0001
242 INTENTIONAL PRODUCT MISUSE 11 0.0001
243 ATRIAL FLUTTER 1 0.0001
244 STENT PLACEMENT 1 0.0001
245 DYSKINESIA 5 0.0001
246 DECUBITUS ULCER 1 0.0001
247 OSTEOPOROSIS 5 0.0001
248 BLOOD UREA INCREASED 2 0.0001
249 HAEMODIALYSIS 1 0.0001
250 CARDIAC MURMUR 1 0.0001
251 MUCOSAL INFLAMMATION 3 0.0001
252 SPINAL OSTEOARTHRITIS 1 0.0001
253 TUMOUR LYSIS SYNDROME 1 0.0001
254 PRODUCT COMMUNICATION ISSUE 1 0.0001
255 LUNG INFILTRATION 1 0.0001
256 BLOOD TRIGLYCERIDES INCREASED 2 0.0001
257 EXOSTOSIS 1 0.0001
258 NERVE COMPRESSION 1 0.0001
259 SPINAL DISORDER 1 0.0001
260 SLEEP APNOEA SYNDROME 2 0.0001
261 SUPRAVENTRICULAR TACHYCARDIA 1 0.0001
262 AFFECT LABILITY 1 0.0001
263 ATELECTASIS 1 0.0001
264 SINUS BRADYCARDIA 1 0.0001
265 BACK PAIN 24 0.0001
266 COELIAC DISEASE 1 0.0001
267 UPPER LIMB FRACTURE 2 0.0001
268 PRESCRIBED UNDERDOSE 2 0.0001
269 EMPHYSEMA 1 0.0001
270 VAGINAL DISCHARGE 1 0.0001
271 EYELID PTOSIS 1 0.0001
272 DRY THROAT 1 0.0001
273 NEUTROPHIL COUNT INCREASED 1 0.0001
274 RIB FRACTURE 2 0.0001
275 PERITONITIS 2 0.0001
276 HYPERBILIRUBINAEMIA 1 0.0001
277 TENDERNESS 1 0.0001
278 DERMATITIS 2 0.0001
279 KNEE ARTHROPLASTY 2 0.0001
280 BREAST CANCER METASTATIC 1 0.0001
281 ALTERED STATE OF CONSCIOUSNESS 2 0.0001
282 CONDITION AGGRAVATED 28 0.0001
283 MENTAL DISORDER 4 0.0001
284 PULMONARY THROMBOSIS 1 0.0001
285 CONSTIPATION 20 0.0001
286 TOOTH FRACTURE 1 0.0001
287 DENTAL CARIES 1 0.0001
288 NERVE INJURY 1 0.0001
289 DRY SKIN 12 0.0001
290 MALNUTRITION 1 0.0001
291 SKIN INFECTION 1 0.0001
292 ELECTROLYTE IMBALANCE 1 0.0001
293 VASCULITIS 1 0.0001
294 COVID-19 PNEUMONIA 1 0.0001
295 BACTERAEMIA 1 0.0001
296 PRODUCTIVE COUGH 4 0.0001
297 HYPERLIPIDAEMIA 1 0.0001
298 MOBILITY DECREASED 6 0.0001
299 C-REACTIVE PROTEIN INCREASED 3 0.0001
300 ADRENAL INSUFFICIENCY 1 0.0001
301 NOCTURIA 1 0.0001
302 SCHIZOPHRENIA 1 0.0001
303 CYTOPENIA 1 0.0001
304 CARDIOMEGALY 1 0.0001
305 TENDON RUPTURE 1 0.0001
306 CYST 1 0.0001
307 ILEUS 1 0.0001
308 TOOTH EXTRACTION 1 0.0001
309 CELLULITIS 4 0.0001
310 ARTHRALGIA 33 0.0001
311 HEPATITIS 2 0.0001
312 ROTATOR CUFF SYNDROME 1 0.0001
313 GENITAL HAEMORRHAGE 1 0.0001
314 INFUSION SITE PAIN 1 0.0001
315 ABDOMINAL PAIN 18 0.0001
316 DEAFNESS 2 0.0001
317 SEDATION 2 0.0001
318 BEDRIDDEN 1 0.0001
319 PULMONARY CONGESTION 1 0.0001
320 SARS-COV-2 TEST POSITIVE 1 0.0001
321 EAR INFECTION 2 0.0001
322 ABORTION SPONTANEOUS 3 0.0001
323 HAIR TEXTURE ABNORMAL 1 0.0001
324 MALIGNANT MELANOMA 1 0.0001
325 JOINT RANGE OF MOTION DECREASED 1 0.0001
326 SINUS CONGESTION 1 0.0001
327 RASH PRURITIC 4 0.0001
328 DECREASED APPETITE 17 0.0001
329 CORONARY ARTERY OCCLUSION 1 0.0001
330 ORAL DISCOMFORT 1 0.0001
331 COORDINATION ABNORMAL 1 0.0001
332 APHONIA 1 0.0001
333 MASS 1 0.0001
334 BLOOD TEST ABNORMAL 1 0.0001
335 SEASONAL ALLERGY 1 0.0001
336 DIALYSIS 1 0.0001
337 SINUS TACHYCARDIA 1 0.0001
338 RED BLOOD CELL COUNT DECREASED 2 0.0001
339 ANGINA PECTORIS 2 0.0001
340 APATHY 1 0.0001
341 DRUG DEPENDENCE 11 0.0001
342 ASCITES 2 0.0001
343 CARDIOMYOPATHY 1 0.0001
344 PULMONARY MASS 1 0.0001
345 THERAPEUTIC PRODUCT EFFECT DECREASED 3 0.0001
346 RASH 29 0.0001
347 CORONARY ARTERY DISEASE 2 0.0001
348 ECONOMIC PROBLEM 1 0.0001
349 DEPRESSION 15 0.0001
350 PLEURAL EFFUSION 4 0.0001
351 HIP ARTHROPLASTY 1 0.0001
352 DEVICE RELATED INFECTION 1 0.0001
353 LYMPHOMA 1 0.0001
354 ANKLE FRACTURE 1 0.0001
355 CYANOSIS 1 0.0001
356 ABDOMINAL PAIN UPPER 13 0.0001
357 OBESITY 1 0.0001
358 SENSORY DISTURBANCE 1 0.0001
359 INTERSTITIAL LUNG DISEASE 3 0.0001
360 BACK DISORDER 1 0.0001
361 BLOOD CREATININE INCREASED 4 0.0001
362 ALOPECIA 12 0.0001
363 PHOTOSENSITIVITY REACTION 1 0.0001
364 GENERALISED TONIC-CLONIC SEIZURE 1 0.0001
365 EXPIRED PRODUCT ADMINISTERED 2 0.0001
366 FALL 20 0.0001
367 LIP SWELLING 2 0.0001
368 SKIN DISORDER 2 0.0001
369 UPPER GASTROINTESTINAL HAEMORRHAGE 1 0.0001
370 CANDIDA INFECTION 1 0.0001
371 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 3 0.0001
372 ORTHOSTATIC HYPOTENSION 1 0.0001
373 BURNING SENSATION 4 0.0001
374 HYPOXIA 2 0.0001
375 DIARRHOEA 36 0.0001
376 LEUKOCYTOSIS 1 0.0001
377 TOOTHACHE 1 0.0001
378 END STAGE RENAL DISEASE 1 0.0001
379 DYSURIA 2 0.0001
380 CONJUNCTIVITIS 1 0.0001
381 INFLUENZA 6 0.0001
382 THINKING ABNORMAL 1 0.0001
383 BACTERIAL INFECTION 1 0.0001
384 MIDDLE INSOMNIA 1 0.0001
385 TUBULOINTERSTITIAL NEPHRITIS 1 0.0001
386 HEPATIC CIRRHOSIS 1 0.0001
387 BLOOD SODIUM DECREASED 1 0.0001
388 PROTEINURIA 1 0.0001
389 MUSCULOSKELETAL DISORDER 1 0.0001
390 POST PROCEDURAL COMPLICATION 1 0.0001
391 CHOKING 1 0.0001
392 PREGNANCY 1 0.0000
393 CYTOKINE RELEASE SYNDROME 1 0.0000
394 CARDIAC FAILURE CONGESTIVE 4 0.0000
395 PROSTATE CANCER 4 0.0000
396 PRODUCT ADMINISTRATION ERROR 1 0.0000
397 THERAPEUTIC RESPONSE DECREASED 3 0.0000
398 BONE MARROW FAILURE 1 0.0000
399 PRODUCT PREPARATION ERROR 1 0.0000
400 MOUTH ULCERATION 1 0.0000
401 OFF LABEL USE 41 0.0000
402 NAUSEA 37 0.0000
403 DEEP VEIN THROMBOSIS 3 0.0000
404 VAGINAL HAEMORRHAGE 2 0.0000
405 ANXIETY 13 0.0000
406 PERIPHERAL SWELLING 7 0.0000
407 INFUSION RELATED REACTION 3 0.0000
408 RENAL FAILURE 6 0.0000
409 TRANSAMINASES INCREASED 1 0.0000
410 HEART RATE IRREGULAR 1 0.0000
411 PAIN 27 0.0000
412 ERYTHEMA 9 0.0000
413 SHOCK 1 0.0000
414 UPPER RESPIRATORY TRACT INFECTION 2 0.0000
415 BLOOD CHOLESTEROL INCREASED 2 0.0000
416 ASTHENIA 16 0.0000
417 ARRHYTHMIA 2 0.0000
418 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 3 0.0000
419 COMA 2 0.0000
420 DIABETIC KETOACIDOSIS 1 0.0000
421 LOCALISED INFECTION 1 0.0000
422 RESPIRATORY FAILURE 3 0.0000
423 CEREBRAL INFARCTION 1 0.0000
424 LUNG DISORDER 2 0.0000
425 LIVER INJURY 1 0.0000
426 ENCEPHALOPATHY 1 0.0000
427 BLOOD ALKALINE PHOSPHATASE INCREASED 1 0.0000
428 PNEUMONIA ASPIRATION 1 0.0000
429 HEADACHE 25 0.0000
430 ACUTE KIDNEY INJURY 6 0.0000
431 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 1 0.0000
432 ANAPHYLACTIC SHOCK 1 0.0000
433 UNRESPONSIVE TO STIMULI 1 0.0000
434 ABDOMINAL DISTENSION 4 0.0000
435 DEHYDRATION 5 0.0000
436 DRY MOUTH 3 0.0000
437 LIMB INJURY 1 0.0000
438 PNEUMONITIS 1 0.0000
439 INFLUENZA LIKE ILLNESS 3 0.0000
440 DRUG INEFFECTIVE 48 0.0000
441 HAEMATOCHEZIA 2 0.0000
442 RESPIRATORY DISTRESS 1 0.0000
443 ABNORMAL DREAMS 1 0.0000
444 DIVERTICULITIS 1 0.0000
445 MENTAL STATUS CHANGES 1 0.0000
446 MEDICATION ERROR 2 0.0000
447 OXYGEN SATURATION DECREASED 2 0.0000
448 HYPONATRAEMIA 2 0.0000
449 INTENTIONAL DOSE OMISSION 1 0.0000
450 INTERNATIONAL NORMALISED RATIO INCREASED 1 0.0000
451 HERPES ZOSTER 2 0.0000
452 SEIZURE 4 0.0000
453 INFECTION 5 0.0000
454 DYSSTASIA 1 0.0000
455 MALAISE 15 0.0000
456 PAIN IN EXTREMITY 10 0.0000
457 ACUTE MYOCARDIAL INFARCTION 1 0.0000
458 WHEEZING 2 0.0000
459 RESPIRATORY DISORDER 1 0.0000
460 ADVERSE DRUG REACTION 3 0.0000
461 IRRITABILITY 2 0.0000
462 JOINT SWELLING 4 0.0000
463 LACRIMATION INCREASED 1 0.0000
464 ADVERSE EVENT 3 0.0000
465 LIMB DISCOMFORT 1 0.0000
466 WEIGHT DECREASED 9 0.0000
467 FATIGUE 25 0.0000
468 DRUG-INDUCED LIVER INJURY 1 0.0000
469 DYSPHAGIA 3 0.0000
470 DRUG INTERACTION 5 0.0000
471 HYPOTHYROIDISM 1 0.0000
472 AMNESIA 2 0.0000
473 SWELLING FACE 2 0.0000
474 OSTEONECROSIS 1 0.0000
475 HEART RATE INCREASED 3 0.0000
476 FEBRILE NEUTROPENIA 2 0.0000
477 VISUAL ACUITY REDUCED 1 0.0000
478 INSOMNIA 8 0.0000
479 URINARY RETENTION 1 0.0000
480 GAIT INABILITY 1 0.0000
481 SOMNOLENCE 6 0.0000
482 TOXICITY TO VARIOUS AGENTS 5 0.0000
483 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 1 0.0000
484 ANGER 1 0.0000
485 DRUG EXPOSURE DURING PREGNANCY 1 0.0000
486 HAEMOGLOBIN DECREASED 3 0.0000
487 ILLNESS 3 0.0000
488 NIGHTMARE 1 0.0000
489 DELIRIUM 1 0.0000
490 HYPERKALAEMIA 1 0.0000
491 LYMPHADENOPATHY 1 0.0000
492 HYPERGLYCAEMIA 1 0.0000
493 EYE SWELLING 1 0.0000
494 HALLUCINATION 2 0.0000
495 MUSCULAR WEAKNESS 3 0.0000
496 CHRONIC KIDNEY DISEASE 2 0.0000
497 ANAEMIA 5 0.0000
498 WHITE BLOOD CELL COUNT INCREASED 1 0.0000
499 PLASMA CELL MYELOMA 1 0.0000
500 PALPITATIONS 3 0.0000
501 ABNORMAL BEHAVIOUR 1 0.0000
502 DEVICE BREAKAGE 1 0.0000
503 OEDEMA PERIPHERAL 3 0.0000
504 BLINDNESS 1 0.0000
505 CARDIAC ARREST 2 0.0000
506 PRODUCT USE IN UNAPPROVED INDICATION 6 0.0000
507 RHABDOMYOLYSIS 1 0.0000
508 POLLAKIURIA 1 0.0000
509 RENAL IMPAIRMENT 2 0.0000
510 RENAL FAILURE ACUTE 1 0.0000
511 HYPOACUSIS 1 0.0000
512 BALANCE DISORDER 2 0.0000
513 MYOCARDIAL INFARCTION 4 0.0000
514 DRUG WITHDRAWAL SYNDROME 2 0.0000
515 TACHYCARDIA 2 0.0000
516 GASTROINTESTINAL DISORDER 2 0.0000
517 LOWER RESPIRATORY TRACT INFECTION 1 0.0000
518 MEMORY IMPAIRMENT 3 0.0000
519 HYPERSENSITIVITY 4 0.0000
520 RENAL DISORDER 1 0.0000
521 BREAST CANCER 2 0.0000
522 CARDIAC DISORDER 2 0.0000
523 VOMITING 10 0.0000
524 DYSPNOEA 12 0.0000
525 PULMONARY EMBOLISM 2 0.0000
526 MIGRAINE 2 0.0000
527 MULTIPLE SCLEROSIS 1 0.0000
528 CONTUSION 2 0.0000
529 HYPOGLYCAEMIA 1 0.0000
530 ATRIAL FIBRILLATION 2 0.0000
531 PRODUCT DOSE OMISSION ISSUE 6 0.0000
532 FLUID RETENTION 1 0.0000
533 BLOOD PRESSURE INCREASED 3 0.0000
534 CHEST DISCOMFORT 2 0.0000
535 HOSPITALISATION 3 0.0000
536 ACCIDENTAL EXPOSURE TO PRODUCT 2 0.0000
537 MUSCULOSKELETAL PAIN 1 0.0000
538 SPEECH DISORDER 1 0.0000
539 PARAESTHESIA 3 0.0000
540 DEPRESSED MOOD 1 0.0000
541 BRADYCARDIA 1 0.0000
542 SEPSIS 2 0.0000
543 ABDOMINAL DISCOMFORT 3 0.0000
544 COUGH 5 0.0000
545 BLISTER 1 0.0000
546 EYE PAIN 1 0.0000
547 MYALGIA 3 0.0000
548 SURGERY 1 0.0000
549 FEELING ABNORMAL 4 0.0000
550 STOMATITIS 1 0.0000
551 ILL-DEFINED DISORDER 1 0.0000
552 VERTIGO 1 0.0000
553 MUSCLE SPASMS 3 0.0000
554 FEELING HOT 1 0.0000
555 CHEST PAIN 3 0.0000
556 PRODUCT USE ISSUE 3 0.0000
557 BLOOD GLUCOSE INCREASED 3 0.0000
558 GAIT DISTURBANCE 3 0.0000
559 LOSS OF CONSCIOUSNESS 2 0.0000
560 BLOOD PRESSURE DECREASED 1 0.0000
561 NEOPLASM MALIGNANT 1 0.0000
562 HYPOTENSION 3 0.0000
563 NEUTROPENIA 2 0.0000
564 INJURY 1 0.0000
565 AGITATION 1 0.0000
566 BRONCHITIS 1 0.0000
567 HOT FLUSH 1 0.0000
568 THROMBOSIS 1 0.0000
569 CONFUSIONAL STATE 2 0.0000
570 DIZZINESS 6 0.0000
571 GASTROINTESTINAL HAEMORRHAGE 1 0.0000
572 URTICARIA 2 0.0000
573 CEREBROVASCULAR ACCIDENT 2 0.0000
574 PYREXIA 4 0.0000
575 PRODUCT STORAGE ERROR 1 0.0000
576 INTENTIONAL PRODUCT USE ISSUE 1 0.0000
577 COVID-19 2 0.0000
578 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 2 0.0000
579 SUICIDAL IDEATION 1 0.0000
580 SWELLING 1 0.0000
581 NEUROPATHY PERIPHERAL 1 0.0000
582 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 2 0.0000
583 MALIGNANT NEOPLASM PROGRESSION 1 0.0000
584 SINUSITIS 1 0.0000
585 PLATELET COUNT DECREASED 1 0.0000
586 OVERDOSE 2 0.0000
587 THROMBOCYTOPENIA 1 0.0000
588 DISEASE PROGRESSION 1 0.0000
589 VISUAL IMPAIRMENT 1 0.0000
590 INJECTION SITE ERYTHEMA 1 0.0000
591 HYPERHIDROSIS 1 0.0000
592 PRODUCT QUALITY ISSUE 1 0.0000
593 VISION BLURRED 1 0.0000
594 DEATH 6 0.0000
595 TREMOR 1 0.0000
596 NO ADVERSE EVENT 1 0.0000
597 NASOPHARYNGITIS 1 0.0000
598 WEIGHT INCREASED 1 0.0000